EXELIXIS, INC.
Biological Products, (No Diagnostic Substances)·ALAMEDA, CA·FY end 01/01·CIK 939767
CEO Pay Ratio
81:1
Dr. Morrissey
CEO Total Comp
$33.2M
Dr. Morrissey
Median Employee
$410,693
Revenue
$2.3B
FY 2025
Net Income
$782.6M
FY 2025
Free Cash Flow
$875.8M
FY 2025
Net Margin
33.7%
Insider Net (180d)
-$22.5M
1 buys / 18 sales
CEO Pay Accountability
CEO comp as % of net income
4.25%
For every $1,000 of profit, $42.47 flows to the CEO.
CEO comp as % of buybacks
3.51%
CEO comp equals 35.1‰ of cash returned to shareholders via buybacks.